+91-9818 456 444
admin@inphog.org
Home
Who We Are
About Us
Our Team
PHO-IAP & Genesis of INPHOG
Reports & Newsletters
Annual Reports
News Letters
Financials
What We Do
Clinical Trials
Sub-Committees
Member Institutions
What We Do
Clinical Trials
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia & Ch Myel (AML)
Hodgkin’s Lymphoma (HL)
Non-Hodgkin Lymphoma (NHL)
Histiocytosis (HIST)
Central Nervous System Tumours(CNS)
Neuroblastoma (NB)
Retinoblastoma (RB)
Wilms Tumour (WT)
Liver Tumours (LM)
PNET
Osteosarcoma (OST)
Soft Tissue Sarcoma (STS)
Germ Cell Tumours & Rare Tumour (GCTRT)
Hematopoietic Stem Cell Transplant (HSCT)
Access to Care
Supportive Care
Surv & Late Eff (LE)
Palliative Care
Cancer Genetics
Cell & Gene Therapy
Hemoglobinopathy & /RBC Disorders
Platelet & Coagulation Disorders
Bone Marrow Failure
Sub-Committees
Member Institutions
What We Do
Clinical Trials
Acute Lymphoblastic Leukemia (ALL)
Acute Myeloid Leukemia & Chronic Myeloproliferative Disorder (AML/CML)
Hodgkin’s Lymphoma (HL)
Non-Hodgkin Lymphoma (NHL)
Histiocytosis (HIST)
Central Nervous System Tumours (CNS)
Neuroblastoma (NB)
Retinoblastoma (RB)
Wilms Tumour (WT)
Liver Tumours (LIV)
Ewing Sarcoma / Primitive Neuroectodermal Tumours (PNET)
Osteosarcoma (OST)
Soft Tissue Sarcoma (STS)
Germ Cell Tumours & Rare Tumour (GCT/RARE)
Hematopoietic Stem Cell Transplant (SCT)
Access To Care (ACC)
Supportive Care (SUPP)
Epidemiology (EPI)
Surv & Late Eff (LE)
Palliative Care (PALL)
Cancer Genetics (GEN)
Cell & Gene Therapy (CELL)
Hemoglobinopathy & RBC Disorders (RBC)
Platelet & Coagulation Disorders (PLAT)
Bone Marrow Failure (BMF)
Sub-Committees
Hematolymphoid Neoplasm
SOLID Tumours
Transversal
Benign Hematology Disorders
Member Institutions
Impact
Connect With Us
Media
Newsletters
Events
Donate Now
InPOG-AML-16-01
Radhakrishnan V, Bakhshi S, Kayal S, Thampy C, Batra A, Shenoy PK, Kumar H, Rajaraman S, Chaudhary S, Bisht R, Dubashi B, Ganesan TS. Two-drug versus three-drug induction chemotherapy in pediatric acute myeloid leukemia: a randomized controlled trial. Blood Cancer J. 2022 Sep 6;12(9):131. doi: 10.1038/s41408-022-00726-1. Erratum in: Blood Cancer J. 2022 Sep 27;12(9):139. PMID: 36068213; PMCID: PMC9444698